GS Investments’s Bristol-Myers Squibb BMY Stock Holding History

GS Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-35,525	Closed	-$2.46M	–	143
2023 Q1	$2.46M	Sell	35,525 -155	-0.4%	-$10.9K	1.42%	28
2022 Q4	$2.57M	Buy	35,680 +130	+0.4%	+$9.8K	1.59%	23
2022 Q3	$2.53M	Sell	35,550 -188	-0.5%	-$13.6K	1.67%	23
2022 Q2	$2.62M	Sell	35,738 -1,081	-3%	-$82.3K	1.5%	26
2022 Q1	$2.8M	Buy	36,819 +2	+0%	+$134	1.58%	24
2021 Q4	$2.3M	Sell	36,817 -840	-2%	-$49.3K	1.11%	35
2021 Q3	$2.23M	Buy	+37,657	New	+$2.48M	1.17%	34
2021 Q1	–	Sell	-26,444	Closed	-$1.64M	–	72
2020 Q4	$1.64M	Buy	+26,444	New	+$1.63M	1.59%	21

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

GS Investments's BMY Position: Q2 2023 in Review

GS Investments sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 35,525 shares — an estimated $2.46M sold.

GS Investments first reported a position in BMY in Q4 2020 and held it in 8 quarters. The position peaked at $2.8M in Q1 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

GS Investments reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
GS Investments sold 35,525 Bristol-Myers Squibb shares in Q2 2023, an estimated $2.46M.
GS Investments first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 8 quarters.
GS Investments's Bristol-Myers Squibb position peaked at $2.8M in Q1 2022.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on GS Investments's 13F filing for Q2 2023, filed 4 Aug 2023.